CS274041B1 - Genically recombined bacterial cells escherichia coli - Google Patents
Genically recombined bacterial cells escherichia coli Download PDFInfo
- Publication number
- CS274041B1 CS274041B1 CS77189A CS77189A CS274041B1 CS 274041 B1 CS274041 B1 CS 274041B1 CS 77189 A CS77189 A CS 77189A CS 77189 A CS77189 A CS 77189A CS 274041 B1 CS274041 B1 CS 274041B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- cells
- bacterial cells
- protein
- escherichia coli
- pek17
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 13
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 21
- 239000000427 antigen Substances 0.000 claims abstract description 6
- 102000036639 antigens Human genes 0.000 claims abstract description 6
- 108091007433 antigens Proteins 0.000 claims abstract description 6
- 241000714266 Bovine leukemia virus Species 0.000 claims description 16
- 101710121417 Envelope glycoprotein Proteins 0.000 claims description 4
- 102100021696 Syncytin-1 Human genes 0.000 claims description 4
- 241000700605 Viruses Species 0.000 abstract description 10
- 241000283690 Bos taurus Species 0.000 abstract description 9
- 241001465754 Metazoa Species 0.000 abstract description 9
- 238000003127 radioimmunoassay Methods 0.000 abstract description 6
- 208000032839 leukemia Diseases 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 3
- 238000002255 vaccination Methods 0.000 abstract description 2
- 235000015278 beef Nutrition 0.000 abstract 3
- 238000002965 ELISA Methods 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 229920001220 nitrocellulos Polymers 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 108010077805 Bacterial Proteins Proteins 0.000 description 2
- 101000920732 Bovine leukemia virus Envelope glycoprotein Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 101500007117 Bovine leukemia virus Surface protein Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 101710081103 Cuticular glutathione peroxidase Proteins 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 101710149086 Nuclease S1 Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 101800001271 Surface protein Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007435 diagnostic evaluation Methods 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- -1 glycol ester Chemical class 0.000 description 1
- 108010011013 glycoprotein GP51 Proteins 0.000 description 1
- 108091005608 glycosylated proteins Proteins 0.000 description 1
- 102000035122 glycosylated proteins Human genes 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- IZXGZAJMDLJLMF-UHFFFAOYSA-N methylaminomethanol Chemical compound CNCO IZXGZAJMDLJLMF-UHFFFAOYSA-N 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 238000003156 radioimmunoprecipitation Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Vynález sa týká génovo zrekombinovaných bakteriálnych buniek Escherichla coli produkujúcich blelkovinu kódovánu expresným 'plazmidom s nakloňovaným génom pře syntézu obalových pl ykupi() ti: íitov virusu leukémie hovadzieho dobytka /BLV/.SUMMARY OF THE INVENTION The present invention relates to a gene recombined bacterial cell of Escherichla coli producing a protein encoded by an expression cloned gene plasmid for the synthesis of envelope cells (BIT) of bovine leukemia virus (BLV).
< t<t
Leukóza hovadzieho dobytka je infekčně ochorenie, horizontálně sa šíriace, ktorého puvudcum je IILV. Virusem indukované lymruprolllorutívno uchoronio Jo sprovádzané zmonuini v krvi infikovaných zvierat, čo sa využívalo v diagnostike. Súčasné testy včasnej diagnostiky rádloimunologické /R1A/ a imunocnzymatické /ELISA/ sú nepriame a sú založené na přítomnost protilátek proti BLV v sérach infikovaných zvierat /Devare, S.G., Chander,Bovine leukosis is an infectious disease, horizontally spreading, whose pududum is IILV. Virus-induced lymruprolllututively uchoronio Jo accompanied by zmonuini in the blood of infected animals, which was used in diagnostics. Recent early radioimmunoassay (R1A) and immunoczymatic (ELISA) tests are indirect and based on the presence of BLV antibodies in sera of infected animals / Devare, S.G., Chander,
5., Samagh, B.S., Stephenson, 3.R.: Evalution of radioimmunoprecipitation for the deteclien of hovine leukemia virus infection in domestic cattle. J. Immunol. 119. /199/, 277; Λ1toner, C., Zajac, V., Bán, J.: A simple and inexpensive method for detection of BLV Infected cattle baued on u mudlfiod ELISA prlnciplo. Zbl. Vet. Med. B. 29, /1902/, 503.5., Samagh, B.S., Stephenson, 3R .: Evalution of Radioimmunoprecipitation for Detection of Bovine Leukemia Virus Infection in Domestic Cattle. J. Immunol. 119 (199), 277; Ton1toner, C., Zajac, V., Bán, J .: A Simple and Inexpensive Method for Detection of BLV Infected Cattle Baued on Mudlfiod ELISA Prlnciplo. Zbl. Vet. Med. B. 29, (1902), 503.
V týchto testoch antigénmi sú Strukturálně bielkoviny BLV. Producentom virusu sú převážou embryonálně ovčie obličkové buriky /FLK/ infikované BLV /Van Rer Maaten, M.J., Miller, J.M.: Repllculion of Dovine leukemia virus in monolayer coli cultures. Bibllo. Kacmatol. 43, /1976/, 360. Virus produkovaný buňkami FLK do rastového média sa z média koncentruje a purifikuje centrifugáciou při vysokých obrátkách /centrifúgy firmy Beckman/ 1’rudukcia virusu FLK buňkami má určitý limit a dlhodobými kultiváclaml sa znižujo. KulInváci a buniek produkti júr.l ch BLV Je velmi náročná na vybovonio /tnrmo3tnty, centrlfúny/, na sterilitu a na trvalé a drahé rastové médiá obohacované výživnými telacími sérami. Bielkoviny telacieho séra z rastového média je velmi tažko oddělit od virusu, čo síažuje diagnostické vyhodnocovanie vzhladom na to, že ide o přítomné homológne bielkoviny, ktorú sposobujú pseudopozitivitu.In these assays, the antigens are Structural BLV proteins. The virus producers are predominantly embryonic sheep kidney burrows (FLK) infected with BLV / Van Rer Maaten, M.J., Miller, J.M .: Replication of Dovine Leukemia Virus in Monolayer Coli Cultures. Bibllo. Kacmatol. 43, (1976), 360. The virus produced by FLK cells into growth medium is concentrated from the medium and purified by high-speed centrifugation (Beckman centrifuge). The reduction of FLK virus by cells has a certain limit and decreases with long-term cultures. BLV CULTIVATION AND CELL PRODUCTS It is very demanding in terms of excellence, centrifuges, sterility and durable and expensive growth media enriched with nourishing calf sera. The calf serum proteins from the growth medium are very difficult to separate from the virus, which makes diagnostic evaluation more difficult because they are homologous proteins present, which are caused by pseudopositivity.
Uvedené nedostatky odstraňujú génovo zrekombinované bakteriálně buňky Eschrichia culi ÚLU pEK17-5 produkujúcc bielkoviny p60 antigénnej špecificity obalového glykoproteína virusu leukémie hovadzieho dobytka. Buňky sú uložené v zbierke bakteriálnych buniek Ústavu experimentálněj onkológie SAV v Bratislavě, ul. Čs. armády 21, pod označením ÚEO pEK17-5.These deficiencies are eliminated by the gene recombined bacterial cells of Eschrichia culi ÚLU pEK17-5 producing p60 proteins of the antigen specificity of the envelope glycoprotein of bovine leukemia virus. The cells are stored in a collection of bacterial cells of the Institute of Experimental Oncology of the Slovak Academy of Sciences in Bratislava, ul. MS. Army 21, under the designation ÚEO pEK17-5.
Buňky ÚEO pEKL7-5 boli získané transformáciou buniek Escherichla cóli kmen TK1046 /Wcinstock, G.M., Rhys, C., Bermon, M. L., Hampar, B., Jackson, D., Šilhavý, T.J., Weisemann, J., Zweig, M.; Open reading frame expression vectors: A generál method for antigen production in Escherichia coli using protein fusions to O-galactosidace. Proč. Nati. Acad. Sci. USA 80, /1983/, 4432, expresným rekombinantným vektorom pORFl, v ktorom je naklónovaný gén pre syntézu obalových glykoproteínov BLV - gp51 a gp30. Takto připravené bakteriálně buňky syntetizujú okrem svojich bielkovín aj novů neglykozylovanú bielkovinu o molekulovej hmotnosti 50 000 až 60 000 daltonov /Ďalej p60/, ktorá je produktem vneseného géna. Imunologické vlastnosti novej bielkoviny boli testované imunoelcktroforetickou metodou /Western blotting/ so sérami z kráv infikovaných BLV. Buňkami ÚLU pCK17-i produkujúca bielkovina p60 je imunologicky reaktívna so sérami z BLV infikovaných zvierat. So sérami neinfikovariých zvierat daná bielkovina nereaguje. Žiadna bielkovina o mol. hmotnosti 60 000 bakteriálnych buniek transformovaných expresným plazmidom bez génu, ktorý kóduje obalové glýkoproteíny BLV, nereaguje so sérami z BLV infikovaných zvierat. Buňky ÚEO pEK17-5 možno množit v štandardných médiách pre bakteriálně buňky - I.B, M9 /Maniatis, T., Fritch, E.F., Sambrook, 3.; Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory, 1982/. Buňky sa můžu uchovávat zmrazené pri -lí)U°C až -20°C , resp. v agare. Rozmražením sa získajú viabilné buňky, ktoré slúžia ako zdroj bielkoviny p60.UEO cells pEKL7-5 were obtained by transforming Escherichla cells with a strain of TK1046 / Wcinstock, GM, Rhys, C., Bermon, ML, Hampar, B., Jackson, D., Silhavy, TJ, Weisemann, J., Zweig, M. ; Open reading frame expression vectors: A general method for antigen production in Escherichia coli using protein fusions to O-galactosidation. Why. Natl. Acad. Sci. USA 80, (1983), 4432, an expression vector recombinant pORF1 in which a gene for the synthesis of envelope glycoproteins BLV-gp51 and gp30 is cloned. The bacterial cells thus prepared synthesize, in addition to their proteins, a novel non-glycosylated protein having a molecular weight of 50,000 to 60,000 daltons (hereinafter p60), which is the product of the introduced gene. The immunological properties of the new protein were tested by immunoelectrophoretic method (Western blotting) with sera from BLV infected cows. The p60 protein-producing ULU cells pCK17-i are immunologically reactive with sera from BLV infected animals. The protein does not react with the sera of non-infectious animals. No protein by mol. weight of 60,000 bacterial cells transformed with an expression plasmid without a gene that encodes BLV envelope glycoproteins does not react with sera from BLV infected animals. UEO cells pEK17-5 can be propagated in standard bacterial cell media - I.B, M9 / Maniatis, T., Fritch, E.F., Sambrook, 3 .; Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory, 1982. Cells can be stored frozen at a temperature between -20 ° C and -20 ° C, respectively. in agar. Thawing yields viable cells that serve as a source of p60 protein.
CS 274 04il 01EN 274 04il 01
V odbornej litcratúre týkajúcej sa leukémie hovádzieho dobytka neboli doteraz publikované práce o príprave a'ntigénnych štruktúr cestou rekombinantných bakteriálnych buniek.The literature on bovine leukemia has not been published to date on the preparation of antigenic structures via recombinant bacterial cells.
Příklad ňltnpnním plnzmldu pllYJD905-20, ktorý obBahuje prakticky kompletný gonóm BLV, restrikčným enzýmom BglII /Biorad/ sa získá 1224 bp DNA fragment, ktorý reprezentuje U4’. génu BLV kódujúceho obalové glykoproteíny. Tento fragment sa inkubuje s nukleázou S^ resp. Bal 31 a klonuje sa do vektora pORFl otvoreného restrikčným enzýmom BamHI /Biorad/ a upraveného tiež nukleázou S^. Týmto rekombinantným plazmidom sa transformovali buňky E. coli kmen MH3000. Rekombinantné plazmidý boli separované z modrých kolonií narastených na LB agare obsahujúcich X-gol /5-bróm-4-chlór-3-indolyl-Q-D-galaktozid/ a z červených kiilónt ( niirii!)tnnýcli nn Mne Conkoy ngnro. DNA rekombinantných plazmidov holi hybridizované s DNA fragmentom kódujúcim obalové glykoproteíny BLV značeným 32P /Amersham/. Restrikč né enzýmy PvuII, Pstl, Smál /Boehringer/ boli použité na určenie orientácie inzertu.An example of the plasmid pIIYJD905-20, which contains a practically complete BLV gonome, with the restriction enzyme BglII (Biorad), yields a 1224 bp DNA fragment that represents U4 '. a BLV gene encoding envelope glycoproteins. This fragment is incubated with nuclease S1 and S4, respectively. Bal 31, and cloned into the pORF1 vector opened with the BamHI restriction enzyme (Biorad) and also nuclease S 4. E. coli strain MH3000 was transformed with this recombinant plasmid. The recombinant plasmids were separated from blue colonies grown on LB agar containing X-gol (5-bromo-4-chloro-3-indolyl-QD-galactoside) and red kiilones (niirii!) Containing Me Conkoy ngnro. Recombinant plasmid DNA was hybridized to a DNA fragment encoding the 32 P-labeled BLV envelope glycoproteins (Amersham). Restriction enzymes PvuII, PstI, Smal (Boehringer) were used to determine the orientation of the insert.
DNA z plazmidov so správnou orientáciou inzertu bola transfekovaná do buniek E.coli kmeň TK1046 a u izolovaných klónov sa sledovala expresía bakteriálnych bielkovín zvýšením kultivačnej teploty z 30°C na 37°C. Bakteriálně buňky boli ňalej rozrušené ultra-2-1 -3-1 zvukom a lyžované v pufrí 1.10 mol.l Tris pH 7.0, 2.10 mol.l fenylmetylsulfonyl fluorid /PMSF/ a 2 mg lyzozým a elektroforeticky delené v 10 % polyakrylamidovom géli /Leammli, U.K.: Cleavege of structural proteins during the assembly of the head of bacteriophage T4. Nátuře 227. /1970/, 680/. Rozdělené bielkoviny boli analyzované metodou Western blotting /Towbin, E., Staehelin, T., Gordon, J.: Elektrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procodure and soine applications. Proč. Nati. Acad. Sci, USA 76, /1979/, 4350/ na nitrocelulóze /Amersham/. Testované hovádzie séra a monoklonálne protilátky proti různým epitopom gp51 boli riaΰυιιύ 1:2UU v puírl /5 sušuné mliuku buz luku, 5.1Ο-2 mul.i’1 Iris pil II.0, II. I 0 2 mol.l'1 NaCl, 2.10'3 mol.l'1 CaCl0, 0.2 % Triton X-100/. Po 24 hod. inkubácii pri 4 °C , -2 -1 bola nitroceluloza s naviazanými proteínmi premytá v TEN pufri /1.10 mol.l Tris pHDNA from plasmids with the correct insert orientation was transfected into E. coli strain TK1046, and the isolated clones were monitored for bacterial protein expression by increasing the culture temperature from 30 ° C to 37 ° C. Bacterial cells were further disrupted by ultra-2-1-3-1 sound and lysed in 1.10 mol.l Tris pH 7.0, 2.10 mol.l phenylmethylsulfonyl fluoride (PMSF) and 2 mg lysozyme and electrophoretically separated in 10% polyacrylamide gel / Leammli. , UK: Cleavege of structural proteins during assembly of T4 bacteriophage head. Nature 227. (1970), 680]. Divided proteins were analyzed by Western blotting / Towbin, E., Staehelin, T., Gordon, J .: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procodure and soine applications. Why. Natl. Acad. Sci. USA 76, (1979), 4350] on nitrocellulose (Amersham). The tested bovine sera and monoclonal antibodies against different epitopes of gp51 were riaΰυιύύ 1: 2UU in puírl / 5 dried milk of either bow, 5.1Ο -2 mul.i -1 of Iris pil II.0, II. I 0 2 mol l '1 NaCl, 2.10 "3 mol l' 0 1 CaCl, 0.2% Triton X-100 /. After 24 hours incubation at 4 ° C, -2 -1, protein-bound nitrocellulose was washed in TEN buffer / 1.10 mol.l Tris pH
7.B, 1.101 mol.l'1 NaCl, 1.10'3 mol.l.1 EDTA /s 0,05 h Tween 20 a inkubovaná s 125Iznačeným proteinem A /Pharmacia/ 2 hod, Po vymytí nitrocelulózy v TEN pufri s 0.05 Tweenom 20 sa vysušila a viazaná rádioaktivita sa sledovala na filme /Kodak/. Vysvětlivky používaných triviálnych názvov: Tris = tris /hydroxymetylaminometan; NaCl - chlorid sodný; CaC^ = chlorid vápenatý; Triton X-100 = oktylfenolpolyetylénglykolester;7.B, 1.10 1 mol.l -1 NaCl, 1.10 ' 3 mol.l. 1 EDTA / with 0.05h Tween 20 and incubated with 125 Labeled Protein A (Pharmacia) for 2 hours. After nitrocellulose was washed in TEN buffer with 0.05 Tween 20, dried and bound radioactivity was monitored on film (Kodak). Explanation of the trivial names used: Tris = tris / hydroxymethylaminomethane; NaCl - sodium chloride; CaCl 2 = calcium chloride; Triton X-100 = octylphenolpolyethylene glycol ester;
EDTA = dvojsodná sol kyseliny etyléndiaminotetraoctovej.EDTA = disodium salt of ethylenediaminotetraacetic acid.
Množstvo bakteriálně produkovanej bielkoviny p60 je za optimálnych podmienok 1 až 4 li z celkových bakteriálnych bielkovín, čo je množstvo dostatočné na využitie tejto bielkoviny v diagnostike. Je vysoko citlivá a Specifická v reakcii s protilátkami proti glykoproteínu gp51.The amount of bacterially produced p60 protein under optimal conditions is 1 to 4% of total bacterial protein, which is sufficient to utilize the protein in diagnostics. It is highly sensitive and specific in response to antibodies to glycoprotein gp51.
Získané bakteriálně buňky ÚEO pEK17-5 majú priemyselné využitie pri velmi nízkých výrobných nákladoch /kultivácia vo fermentoroch/ ako zdroj bielkoviny p60, ktorá sa může použil v diagnostike zvierat infikovaných BLV, V rádioimunoteste /RIA/ alebo imunoenzymatickom teste /ELISA/ může nahradit virusové bielkoviny a slúžil pře kvantitativné a kvalitativně stanovenie cirkulujúcich protilátok proti virusu. Potenciálně je možné využitie týchto buniek resp. izolovanej bielkoviny p60 k vakcinácii zvierat.The obtained bacterial cells of UEO pEK17-5 have industrial use at very low production costs (fermentation culture) as a source of p60 protein, which can be used in the diagnosis of BLV infected animals, in radioimmunoassay (RIA) or immunoenzymatic assay (ELISA) can replace viral proteins and served to quantitatively and qualitatively determine circulating antibodies against the virus. Potentially, the use of these cells, respectively, is possible. isolated p60 protein for animal vaccination.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS77189A CS274041B1 (en) | 1989-02-06 | 1989-02-06 | Genically recombined bacterial cells escherichia coli |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS77189A CS274041B1 (en) | 1989-02-06 | 1989-02-06 | Genically recombined bacterial cells escherichia coli |
Publications (2)
Publication Number | Publication Date |
---|---|
CS77189A1 CS77189A1 (en) | 1990-08-14 |
CS274041B1 true CS274041B1 (en) | 1991-04-11 |
Family
ID=5340454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS77189A CS274041B1 (en) | 1989-02-06 | 1989-02-06 | Genically recombined bacterial cells escherichia coli |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS274041B1 (en) |
-
1989
- 1989-02-06 CS CS77189A patent/CS274041B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS77189A1 (en) | 1990-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Holt et al. | Streptococcus mutans genes that code for extracellular proteins in Escherichia coli K-12 | |
Thole et al. | Use of recombinant antigens expressed in Escherichia coli K-12 to map B-cell and T-cell epitopes on the immunodominant 65-kilodalton protein of Mycobacterium bovis BCG | |
US5037753A (en) | Feline t-lymphotropic lentivirus | |
US5118602A (en) | Feline T-lymphotropic lentivirus assay | |
JP3883569B2 (en) | Peptide fragment of respiratory multinucleated virus protein G, immunogenic agent, pharmaceutical composition containing the same, and production method | |
CN1020752C (en) | Acquired Immunodeficiency Syndrome (AIDS) Vaccine | |
Heeg et al. | Vaccination of class I major histocompatibility complex (MHC)‐restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating‐ovalbumin complexes enter the class I MHC‐restricted antigen pathway and allow sensitization against the immunodominant peptide | |
Barbacid et al. | Avian reticuloendotheliosis viruses: evolutionary linkage with mammalian type C retroviruses | |
Kim et al. | Conformationally appropriate expression of the Toxoplasma antigen SAG1 (p30) in CHO cells | |
Qi et al. | Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers | |
Sato et al. | Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19 | |
Kim et al. | Rapid diagnosis of scrub typhus by a passive hemagglutination assay using recombinant 56-kilodalton polypeptides | |
CN110093360B (en) | A fusion protein of rabies virus G protein expressing Fc fragment and preparation method thereof | |
US4691009A (en) | Hybrid proteins produced by an ultrahigh prokaryotic expression system | |
CN111925452B (en) | Mycoplasma hyopneumoniae genetic engineering subunit vaccine, and preparation method and application thereof | |
JPS62239992A (en) | Development of immunologically reactive virus protein | |
Okuda et al. | Enzyme-linked immunosorbent assay for the detection of canine Leptospira antibodies using recombinant OmpL1 protein | |
Atkinson et al. | Use of bacterial trpE fusion vectors to express and characterize the bovine immunodeficiency-like virus core protein | |
CS274041B1 (en) | Genically recombined bacterial cells escherichia coli | |
Encinas et al. | Antibody recognition of the glycoprotein g of viral haemorrhagic septicemia virus (VHSV) purified in large amounts from insect larvae | |
Burkala et al. | Recombinant Jembrana disease virus proteins as antigens for the detection of antibody to bovine lentiviruses | |
Müller et al. | Cloning of mglB, the structural gene for the galactose-binding protein of Salmonella typhimurium and Escherichia coli | |
Bloom et al. | Molecular comparisons of in vivo-and in vitro-derived strains of Aleutian disease of mink parvovirus | |
JPH02503196A (en) | Vaccine against Brucella abortus | |
CN112094354B (en) | Acinetobacter paragallinarum genetic engineering subunit vaccine, preparation method and application thereof |